EC Paediatrics

Research Article Volume 13 Issue 7 - 2025

Interference of Artificial Intelligence in Preventive Medicinal Pharmacology and Medical Practice in the Context of Medical Ethics: A Cross-Sectional Approach

Athanasios G Simotas1*, M Pispirigkou2, K Pispirigos3 and D Kardamakis1

1Division of Clinical Laboratories, Department of Medicine, School of Health Sciences, University of Patras, Greece
2Division of Oncology, Department of Medicine, School of Health Sciences, University of Patras, Greece
3Director of Clinical Biochemistry Research Center Patras, Greece

*Corresponding Author: Athanasios G Simotas, Division of Clinical Laboratories, Department of Medicine, School of Health Sciences, University of Patras, Greece.
Received: June 05, 2025; Published: June 18, 2025



Enhancing artificial intelligence with medical ethics is an evolving technology that could use only the positive aspects of human thinking and avoid every negative shade, such as coercion, greed, envy, and selfishness. This cross-sectional study that investigates ethical decision-making according to Artificial Intelligence is possible by formulating a program to operate with empathy, sympathy and compassion with application to pharmacology and medical practice. This option finds good use in emergencies, protocol studies, and difficult council split decisions. The use of common sense is an empirical matter, which leads to a technical way of pretraining autonomous robotic mechanisms to act and respond properly to certain concepts, just like a human being might have done. Artificial Intelligence is to be able to make a sound ethical decision in the best interest of the patient.

 Keywords: Artificial Intelligence; Medical Ethics; Pharmacology; Medical Practice; Justice; Autonomy; Beneficence; Non-Maleficence; Best Interest of the Patient

  1. World Health Organization. “Ethics and governance of artificial intelligence for health”. Geneva (2021).
  2. Amisha Malik P., et al. “Overview of artificial intelligence in medicine”. Journal of Family Medicine and Primary Care 8.7 (2019): 2328-23
  3. Mervyn Conroy., et al. “Using practical wisdom to facilitate ethical decision-making: a major empirical study of phronesis in the decision narratives of doctors”. BMC Medical Ethics 1 (2021): 16.
  4. Anne Ssrestha., et al. “Quality of life versus length of life considerations in cancer patients: A systematic literature review”. Psycho-Oncology, APOS 7 (2019): 1367-1380.
  5. Anji Wall., et al. “Ethics in surgery”. Current Problems in Surgery 3 (2013): 99-134.
  6. Hunt P., et al. “Running on empathy: Relationship of empathy to compassion satisfaction and compassion fatigue in cancer healthcare professionals”. European Journal of Cancer Care (England) 28.5 (2019): e13124.
  7. Millar MR., et al. “Ethics of vaccination: Should capability measures be used to inform SARS-CoV-2 vaccination strategies?”British Journal of Clinical Pharmacology 1 (2021): 47-55.
  8. Pugh J. “Autonomy, rationality, and contemporary bioethics”. Oxford (UK): Oxford University Press. Chapter 6, Informed Consent, Autonomy, and Beliefs (2020).
  9. Jonsen AR., et al. “Clinical ethics: A practical approach to ethical decisions in clinical medicine. 7th edition”. New York: McGraw-Hill (2010).
  10. NK Chand. “Management of patients who refuse blood transfusion”. Indian Journal of Anaesthesia 58.5 (2014): 658-664.
  11. Simotas A and Kardamakis D. “Medical ethics in the era of artificial intelligence - A new landscape on medical practice?” AI Legal and Ethical Challenges, IntechOpen (2024).
  12. Robert R., et al. “Ethical dilemmas due to the covid-19 pandemic”. Annals of Intensive Care 10 (2020): 84.
  13. Gohram Baloch., et al. “Risk-based allocation of COVID 19 personal protective equipment under supply shortages”. European Journal of Operation Research 3 (2023): 1085-1100.
  14. Jasmine Reimer. “Supply Chain during COVID-19, what went wrong?” Here (2020).
  15. De Pentheny O’Kelly C., et al. “The impact of culture and religion on truth telling at the end of life”. Nephrology Dialysis Transplantation 26.12 (2011): 3838-38
  16. European Monitoring Center for Drugs and Drun addiction: Viral Hepatitis Policies in Europe, Lisbon (2023).
  17. Alowais SA., et al. “Revolutionizing Healthcare: the role of artificial intelligence in clinical practice”. BMC Medical Education 23 (2023):
  18. Soofi H. “Ethical aspects of facilitating the recruitment of people with dementia for clinical trials: a call for further debate”. British Journal of Clinical Pharmacology 1 (2021): 22-26.
  19. Weisberg Ethan., et al. “GPT-4 and medical image analysis: strengths, weaknesses and future directions”. Journal of Mechatronics and Artificial Intelligence in Engineering 6 (2024).
  20. Magavern EF., et al. “Health equality, race and pharmacogenomics”. British Journal of Clinical Pharmacology1 (2021): 27-33.

Athanasios G Simotas., et al. "Interference of Artificial Intelligence in Preventive Medicinal Pharmacology and Medical Practice in the Context of Medical Ethics: A Cross-Sectional Approach". EC Paediatrics 13.7 (2025): 01-04.